These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 18945306)

  • 21. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
    Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
    Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
    Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
    Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
    Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
    J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
    Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
    J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
    Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
    Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
    Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
    J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases.
    Muniesa C; Estrach T; Pujol RM; Gallardo F; Garcia-Muret P; Climent J; Servitje O
    J Am Acad Dermatol; 2010 Mar; 62(3):418-26. PubMed ID: 20079954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unusual variants of mycosis fungoides.
    Abeldaño A; Arias M; Benedetti A; Ochoa K; Maskin M; Pellerano G; Kien MC; Chouela E
    Skinmed; 2011; 9(4):218-22. PubMed ID: 21980706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PUVA plus interferon α2b in the treatment of advanced or refractory to PUVA early stage mycosis fungoides: a case series.
    Nikolaou V; Siakantaris MP; Vassilakopoulos TP; Papadavid E; Stratigos A; Economidi A; Marinos L; Papadaki T; Antoniou C
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):354-7. PubMed ID: 20586838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD13 and TCR clone: markers of early mycosis fungoides.
    Bernier C; Nguyen JM; Quéreux G; Renault JJ; Bureau B; Dreno B
    Acta Derm Venereol; 2007; 87(2):155-9. PubMed ID: 17340024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of T-cell receptor gene rearrangements in patients with recurrent patch/plaque (T2) CTCL (mycosis fungoides).
    Thayu M; Tallini G; Glusac EJ; Kacinski BM; Wilson LD
    Yale J Biol Med; 1999; 72(6):365-75. PubMed ID: 11138932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
    Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
    Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
    El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.
    Rupoli S; Barulli S; Guiducci B; Offidani M; Mozzicafreddo G; Simonacci M; Filosa G; Giacchetti A; Ricotti G; Brandozzi G; Cataldi I; Serresi S; Ceschini R; Bugatti L; Offidani A; Giangiacomi M; Brancorsini D; Leoni P
    Haematologica; 1999 Sep; 84(9):809-13. PubMed ID: 10477454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.